DERMATA THERAPEUTICS INC (DRMA) Stock Cash Flow
NASDAQ:DRMA - Nasdaq - US2498454055 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -11.46M | -12.29M | -7.79M | -9.61M | -7.90M | |||
| Depreciation Amortization | N/A | N/A | N/A | N/A | 0.00 | |||
| Change In Working Capital | 956.60K | 466.90K | 863.70K | -153.60K | 289.60K | |||
| Interest Paid | N/A | N/A | N/A | 0.00 | 1.40K | |||
| Taxes Paid | N/A | 1.00K | 1.00K | 1.00K | 1.40K | |||
| Other non cash items | 107.70K | 657.70K | 522.10K | 930.30K | 1.92M | |||
| OPERATING CASH FLOW | -10.39M | -11.16M | -6.41M | -8.83M | -5.69M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | 1.01M | |||
| Stock Issued/Repurchased | 15.43M | 6.89M | 7.61M | 4.28M | 14.96M | |||
| Other Financing Activity | -51.30K | -800.00 | 0.00 | N/A | N/A | |||
| FINANCING CASH FLOW | 15.38M | 6.89M | 7.61M | 4.28M | 15.96M | |||
| CHANGE IN CASH | 4.99M | -4.28M | 1.20M | -4.56M | 10.27M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -10.39M | -11.16M | -6.41M | -8.83M | -5.69M | |||
| FREE CASH FLOW | -10.39M | -11.16M | -6.41M | -8.83M | -5.69M | |||
All data in USD